Why Epcoritamab for My CLL Clinical Trial?
It’s an immune therapy because we harness our immune system to kill the cancer. No toxic chemotherapy.
Smart Patients Get Smart Care™
The World’s Leading Authority for Chronic Lymphocytic Leukemia Patients
It’s an immune therapy because we harness our immune system to kill the cancer. No toxic chemotherapy.
The Food and Drug Administration (FDA)‘s draft guidance on clinical outcome assessments (COA) gave CLL Society an opportunity to share with the Agency why CLL can be a difficult area for research & development (R&D), and that, as a chronic blood cancer, treatment value from a patient’s perspective might turn more towards durability of response.
Very complex, promising research is currently underway to use humanized bispecific single-domain antibodies (bsVHH). But, unfortunately, harnessing the immune system can get very complicated. This article introduces an experimental antibody with a novel approach to fighting CLL / SLL.
What follows is our patient-friendly summary of this research.: BMF-219, an irreversible menin inhibitor that demonstrated strong preclinical activity against chronic lymphocytic leukemia or CLL patients’ specimens, including those with high-risk markers.
Discussion of a phase 3 clinical trial in progress, investigating the efficacy of the triple combination of ibrutinib plus venetoclax and obinutuzumab with response-dependent discontinuation.
Join CLL Society and Dr. Adrian Wiestner with National Institutes of Health (NIH) and clinical trials nurse Kaitlin Kennard with UPENN to learn more about clinical trials, who should consider participating, what questions you should ask, and your rights. Christina Rodriguez Fuller will share her experience in a clinical trial as part of her frontline treatment for CLL.
Is a Clinical Trial Right for You? Monday, May 16, 2022 11 AM PT, 12 PM MT, 1 PM CT, 2 PM ET (Duration 75 minutes) Register Now! Description: Clinical trials
CLL / SLL Opening Trials & Status Updates Opening Trials & Status Updates Clinical Trials can greatly broaden the potential for effective treatment for your CLL. When CLL / SLL trials
Clinical Trial Basics In this section you can learn the basics about clinical trials, including FAQs, trial phases, how to navigate Clinicaltrials.gov, and much more… Clinical Trial Basics In this section you
One click to our most popular content.
Cookie | Duration | Description |
---|---|---|
cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |